A group of plaintiffs has filed a new Xarelto lawsuit in the current MDL, proceeding in the U.S. District Court for the Eastern District of Louisiana. The plaintiffs include three families who lost loved ones allegedly because of serious Xarelto side effects, as well as…
Since October 2015, federal Zofran lawsuits have been consolidated in the U.S. District Court for the District of Massachusetts. Just a couple months after consolidation, manufacturer GlaxoSmithKline (GSK) filed a motion to dismiss all of the cases pending in the newly established MDL, “as preempted
On November 13, 2015, a Texas woman filed a new Invokana lawsuit against manufacturers Janssen Pharmaceuticals and parent company Johnson & Johnson (J&J). She blames the defendants for the serious injuries she suffered after taking the type 2 diabetes drug. The case was filed in…
Is the FDA doing enough to protect the public from potentially serious drug side effects? According to a recently released Government Accountability Office (GAO) report, it doesn’t look like it. Though the administration approved many drugs between 2006 and 2014 through their “fast-track” processes,
In June 2014, all federally filed testosterone replacement lawsuits were consolidated into one court in the Northern District of Illinois. Since then, thousands of lawsuits have joined the litigation, with about 3,500 cases currently pending there. Plaintiffs claim that the testosterone replacement
Reports of problems with type 2 diabetes drug Invokana (canagliflozin) have continued to increase, according to the Institute for Safe Medicine Practices (ISMP) most recent QuarterWatch for the second quarter of 2015. “Both prescription volume and adverse drug event reports are increasing rapidly fo
A new study links type 2 diabetes drug Onglyza (saxagliptin), an incretin mimetic that stimulates the pancreas to make more insulin after a patient eats a meal, to a small but significant increase for acute pancreatitis. The results of the study, lead by Rury R.…
On December 28, 2015, another Xarelto lawsuit joined the centralized litigation in the Eastern District of Louisiana. The plaintiff, a resident of New Jersey, brought claims against manufacturers Janssen Pharmaceuticals, parent company Johnson & Johnson, and Bayer Pharma AG. There are currently over
On December 14, 2015, a Tennessee man filed a new Invokana lawsuit against manufacturers Janssen Pharmaceuticals, parent company Johnson & Johnson, and Mitsubishi Tanabe Pharma Corp. The plaintiff filed the lawsuit in the U.S. District Court for the Western District of Tennessee, and seeks damages…
For about a year-and-a-half now, federally filed testosterone therapy treatment lawsuits have been proceeding in the centralized litigation in Northern District of Illinois. About 3,500 cases are currently pending there, with most claiming that products like AndroGel, Testim, Androderm, and Axiron c
In May 2015, the FDA released a drug safety communication warning doctors and patients that type 2 diabetes drugs like Invokana may lead to diabetic ketoacidosis (DKA), “a serious condition where the body produces high levels of blood acids called ketones that may require hospitalization.”…
Since April 2012, federally filed Zoloft lawsuits have been proceeding in centralized litigation in the Eastern District of Pennsylvania under the direction of U.S. District Judge Cynthia Rufe. Currently, there are just shy of 300 cases pending against Zoloft manufacturer Pfizer, with plaintiffs cla